[ad_1]
In people without any prior psychiatric condition, COVID-19 appears to increase the risk of developing one, particularly anxiety disorders, insomnia, and dementia. (The Lancet Psychiatry)
And the pandemic is likely magnifying the symptoms of obsessive compulsive disorder in children and young people. (BMC Psychiatry)
Pessimism: a predictor of relapse in bipolar disorder? (Daily science)
Feelings of loneliness tend to peak in 20-year-olds, but plummet in 60-year-olds. (Journal of Clinical Psychiatry)
Among more than 12,000 people in a survey, only 18% said they would rather discuss their mental health with a human rather than a robot. The main reasons? Less judgment and quick, unbiased responses. (CNBC)
How did a Washington-based inpatient geriatric psychiatry unit handle a COVID-19 outbreak? (Journal of the American Psychiatric Nurses Association)
A new study in rats found that investigational 5-HT2A the M100907 receptor antagonist showed promise as a possible treatment for methamphetamine use disorder. (Drug and alcohol dependence)
Researchers from the Albert Einstein School of Medicine and Montefiore Health System in New York City received a $ 4 million grant from the National Institute of Mental Health to study biomarkers of severe depression in adolescents.